A detailed history of Israel Englander (Millennium Management LLC) transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,000 shares of BIO stock, worth $664,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 3,000 33.33%
Holding current value
$664,560
Previous $819,000 18.32%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$263.97 - $344.64 $152 Million - $198 Million
575,643 Added 7057.04%
583,800 $195 Million
Q2 2024

Aug 14, 2024

SELL
$268.26 - $339.48 $3.96 Million - $5.01 Million
-14,754 Reduced 64.4%
8,157 $2.23 Million
Q1 2024

May 15, 2024

SELL
$304.11 - $351.99 $60.9 Million - $70.5 Million
-200,331 Reduced 89.74%
22,911 $7.92 Million
Q4 2023

Feb 14, 2024

SELL
$269.37 - $365.04 $8.98 Million - $12.2 Million
-33,322 Reduced 12.99%
223,242 $72.1 Million
Q2 2023

Aug 14, 2023

SELL
$359.49 - $486.4 $72.2 Million - $97.6 Million
-200,716 Reduced 43.89%
256,564 $97.3 Million
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $59.5 Million - $71.5 Million
142,199 Added 45.13%
457,280 $219 Million
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $50.5 Million - $65.5 Million
-143,564 Reduced 31.3%
315,081 $132 Million
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $32.7 Million - $44.7 Million
79,316 Added 20.91%
458,645 $191 Million
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $41.5 Million - $53.4 Million
89,424 Added 30.85%
379,329 $188 Million
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $137 Million - $192 Million
261,317 Added 914.08%
289,905 $163 Million
Q4 2021

Feb 14, 2022

SELL
$708.84 - $794.68 $99 Million - $111 Million
-139,654 Reduced 83.01%
28,588 $21.6 Million
Q3 2021

Nov 15, 2021

BUY
$657.71 - $825.77 $28.8 Million - $36.2 Million
43,809 Added 35.21%
168,242 $126 Million
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $40.9 Million - $46 Million
-70,936 Reduced 36.31%
124,433 $80.2 Million
Q1 2021

May 17, 2021

BUY
$547.01 - $662.35 $29.9 Million - $36.2 Million
54,670 Added 38.86%
195,369 $112 Million
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $13.6 Million - $17.2 Million
-26,671 Reduced 15.94%
140,699 $82 Million
Q3 2020

Nov 16, 2020

SELL
$454.43 - $535.6 $4.87 Million - $5.74 Million
-10,722 Reduced 6.02%
167,370 $86.3 Million
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $18.9 Million - $27.8 Million
56,469 Added 46.43%
178,092 $80.4 Million
Q1 2020

May 14, 2020

SELL
$320.01 - $409.07 $47.2 Million - $60.3 Million
-147,356 Reduced 54.78%
121,623 $42.6 Million
Q4 2019

Feb 14, 2020

SELL
$319.73 - $374.2 $64.7 Million - $75.7 Million
-202,382 Reduced 42.94%
268,979 $99.5 Million
Q3 2019

Nov 14, 2019

SELL
$304.55 - $345.24 $16.6 Million - $18.8 Million
-54,563 Reduced 10.37%
471,361 $157 Million
Q2 2019

Aug 15, 2019

BUY
$286.93 - $312.59 $69.3 Million - $75.5 Million
241,650 Added 85.01%
525,924 $164 Million
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $39.2 Million - $42.7 Million
-136,600 Reduced 32.46%
284,274 $19.2 Million
Q1 2019

May 14, 2019

BUY
$224.3 - $317.41 $5.06 Million - $7.16 Million
22,546 Added 5.66%
420,874 $129 Million
Q4 2018

Feb 14, 2019

BUY
$220.1 - $309.0 $4.51 Million - $6.34 Million
20,503 Added 5.43%
398,328 $92.5 Million
Q3 2018

Nov 14, 2018

SELL
$289.28 - $326.15 $55.5 Million - $62.6 Million
-191,918 Reduced 33.69%
377,825 $118 Million
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $71.9 Million - $89.5 Million
294,523 Added 107.01%
569,743 $164 Million
Q1 2018

May 15, 2018

BUY
$233.97 - $274.11 $22.3 Million - $26.1 Million
95,218 Added 52.9%
275,220 $68.8 Million
Q4 2017

Feb 14, 2018

BUY
$216.94 - $271.3 $20.7 Million - $25.8 Million
95,235 Added 112.35%
180,002 $43 Million
Q3 2017

Nov 14, 2017

BUY
$212.27 - $242.28 $18 Million - $20.5 Million
84,767
84,767 $18.8 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.19B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.